BiondVax Pharmaceuticals, Ltd. (NASDAQ: BVXV) Enters into Agreement with Max Planck Society to Develop COVID-19 Nanosized Antibodies
BiondVax Pharmaceuticals, Ltd. (NASDAQ: BVXV) operates as a biopharmaceutical company, which focuses on the research, development, manufacturing, and commercialization of ...